Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants
- ACS Chem Biol. 2021 Apr 16;16(4):571-578. doi: 10.1021/acschembio.0c00960.
- 1. Structural Genomics Consortium and Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.
- 2. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany.
- 3. Medicine Design, Pfizer Worldwide Research Development and Medicine, Eastern Point Road, Groton, Connecticut 06340, United States.
- 4. Medicine Design, Pfizer Worldwide Research Development and Medicine, 1 Portland Street, Cambridge, Massachusetts 02139, United States.
- 5. German Cancer network DKTK and Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.
Dysfunction of YEATS-domain-containing MLLT1, an acetyl/acyl-lysine dependent Epigenetic Reader Domain, has been implicated in the development of aggressive cancers. Mutations in the YEATS domain have been recently reported as a cause of MLLT1 aberrant reader function. However, the structural basis for the reported alterations in affinity for acetylated/acylated histone has remained elusive. Here, we report the crystal structures of both insertion and substitution mutants present in Cancer, revealing significant conformational changes of the YEATS-domain loop 8. Structural comparison demonstrates that not only did such alteration alter the binding interface for acetylated/acylated histones, but the sequence alterations in the loop in T1 mutant may enable dimeric assembly consistent with inducing self-association behavior. Nevertheless, we show that also the MLLT1 mutants can be targeted by developed acetyllysine mimetic inhibitors with affinities similarly to wild-type. Our report provides a structural basis for the altered behaviors and a potential strategy for targeting oncogenic MLLT1 mutants.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Epigenetic Reader DomainResearch Areas: Cancer